Rj Bates
About Rj Bates
Rj Bates is a scientist with over 25 years of experience in the pharmaceutical industry, currently working at Bristol-Myers Squibb in San Diego, CA.
Professional Title and Current Position
Rj Bates is a Scientist currently working at Bristol-Myers Squibb in San Diego, CA. He joined Bristol-Myers Squibb in December 2019. In his role, he leverages his extensive experience in the pharmaceutical industry to contribute to the company's research and development efforts.
Previous Roles and Industry Experience
Rj Bates has over 25 years of experience in the pharmaceutical industry. Before joining Bristol-Myers Squibb, he worked at Celgene as a Scientist for 22 years, from 1997 to 2019. His tenure at Celgene signifies a deep commitment to groundbreaking research and scientific advancements. He also worked at Signal Pharmaceuticals, LLC and as a Graduate Teaching Assistant at San Diego State University from 1994 to 1997.
Educational Background
Rj Bates has a robust educational background that underpins his expertise in the pharmaceutical field. He holds an M.B.A. in Business Administration from CSUSM College of Business (1999 to 2001) and an M.S. in Cellular and Molecular Biology from San Diego State University (1994 to 1997). He also completed a Certificate Program in Intellectual Property at UC San Diego (2003 to 2005). Additionally, Bates earned a B.A. in Biology from California State University, Fullerton (1992 to 1994).
Expertise in Cellular and Molecular Biology
Rj Bates has a strong background in Cellular and Molecular Biology. His academic and professional experiences demonstrate a consistent focus on this area, notably through his M.S. degree in the field from San Diego State University. This expertise is further applied in his ongoing work within the pharmaceutical industry.
Experience in Academic and Corporate Research
Rj Bates has significant experience in both academic and corporate research environments. He served as a Graduate Teaching Assistant at San Diego State University for three years and later transitioned to the corporate sector, where he has held various scientific roles at Celgene, Signal Pharmaceuticals, and currently at Bristol-Myers Squibb. This dual experience provides him with a unique perspective on scientific research and its applications in the pharmaceutical industry.